b'EMPLOYEE SPOTLIGHTNEW HIRE:LINDA THARBYPresident and Chief Executive OfficerLinda Tharby is to be appointed as President and Chief Executive Officer of KORU Medical, effective April 12, 2021. Ms. Tharby is an experienced global medical device industry executive, with a 24-year career with Becton Dickinson and Company (BD; NYSE: BDX), a leading medical technology company. She was a member of the Executive Leadership team of BD that transformed the company from an $8 billion medical supplies company to an $18 billion global medical technology company. With over 20 years of experience in global business leadership roles, Ms. Tharby has been accountable for portfolio innovation and global commercialization across multiple business units. Ms. Tharby also has enterprise change and integration experience, with her most recent role at BD, from July 2018 through December 2020, as the companys Chief Customer Experience Officer and in her prior role, as the companys Chief Human Resources Officer, from October 2016 through July 2018, through BDs $24 billion acquisition and integration of C.R. Bard in 2017. Prior to that, she served at BD as the Executive Vice President and President of the Life Sciences segment, Group President of Preanalytical Systems and BD Biosciences, Worldwide President of Diabetes Care, and Vice President and General Manager of Pharmaceutical Systems. Since 2014, Ms. Tharby has served on the Columbia University School of Public Health Board of Advisors.5 KORU WINTER 2020Q1 2021'